Biotech & MedTech
-
Thomas Smeenk with an update on the FDA Phase II clinical trial program of the Hemostemix blood-derived, stem cell therapeutics product (ACP-01)
In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV:…
-
Awakn announces first-ever study investigating ketamine in gambling addiction treatment
When we think about addiction many people think about drugs, tobacco, and alcohol addiction; but often forget about…
-
Tremendous technologies all based around Molecular Imprinted Polymers have investors riding the Sixth Wave
Sixth Wave continues to achieve outstanding results at detecting COVID-19 as well as the extraction of cannabinoids, gold…
-
Rritual Superfoods’ next quarterly results could be hard to ignore
If you are a current investor or an interested party in Rritual Superfoods Inc. (CSE: RSF | OTCQB:…
-
Awakn Life Sciences’ Anthony Tennyson on using researched backed psychedelic drugs and therapies to treat Alcohol Use Disorder
In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO:…
-
Element Nutritional Sciences Stuart Lowther on Rejuvenate™ in Walgreens, Aging and the Impact on Muscle Health
In a recent InvestorIntel interview, Tracy Weslosky speaks with Stuart Lowther, President, CEO and Founder of Element Nutritional…
-
Using StageZero Life Sciences as a Case Study for the Publication of All Research Reports Online
Analyst Chris Thompson published a piece on eResearch on StageZero Life Sciences Ltd. (TSX: SZLS) this weekend titled,…
-
Anthony Tennyson on Awakn Life Sciences bringing innovation in addiction treatment to the market
In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO:…
